학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 51건 | 목록 1~20
Academic Journal
Stanczak MA; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.; Rodrigues Mantuano N; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Kirchhammer N; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Sanin DE; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.; Jacob F; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Coelho R; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Everest-Dass AV; Institute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast QLD4222, Australia.; Wang J; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Trefny MP; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Monaco G; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Bärenwaldt A; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Gray MA; Department of Chemistry, Stanford ChEM-H, and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA.; Petrone A; Palleon Pharmaceuticals, Waltham, MA 02451, USA.; Kashyap AS; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Glatz K; Institute of Pathology, University Hospital Basel, 4031 Basel, Switzerland.; Kasenda B; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland.; Normington K; Palleon Pharmaceuticals, Waltham, MA 02451, USA.; Broderick J; Palleon Pharmaceuticals, Waltham, MA 02451, USA.; Peng L; Palleon Pharmaceuticals, Waltham, MA 02451, USA.; Pearce OMT; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University, London EC1M 6BQ, UK.; Pearce EL; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.; Bertozzi CR; Department of Chemistry, Stanford ChEM-H, and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA.; Zippelius A; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland.; Läubli H; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Geburtshilfe und Frauenheilkunde.
Academic Journal
Trefny MP; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland. marcel.trefny@unibas.ch.; Kirchhammer N; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Auf der Maur P; Laboratory of Tumor Heterogeneity, Metastasis and Resistance, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Natoli M; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Schmid D; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Germann M; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Fernandez Rodriguez L; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Herzig P; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Lötscher J; Laboratory of Immunobiology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Akrami M; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Stinchcombe JC; Cambridge Institute for Medical Research, Biomedical Campus, Cambridge, CB2 0XY, UK.; Stanczak MA; Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Zingg A; Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Buchi M; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Roux J; Bioinformatics Core Facility, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.; Marone R; Laboratory of Molecular Immune Regulation, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Transplantation Immunology & Nephrology, Basel University Hospital, Basel, Switzerland.; Don L; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Lardinois D; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Wiese M; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Jeker LT; Laboratory of Molecular Immune Regulation, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Transplantation Immunology & Nephrology, Basel University Hospital, Basel, Switzerland.; Bentires-Alj M; Laboratory of Tumor Heterogeneity, Metastasis and Resistance, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Rossy J; Biotechnology Institute Thurgau, University of Konstanz, Kreuzlingen, Switzerland.; Thommen DS; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Griffiths GM; Cambridge Institute for Medical Research, Biomedical Campus, Cambridge, CB2 0XY, UK.; Läubli H; Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Medical Oncology, University Hospital Basel, Basel, Switzerland.; Hess C; Laboratory of Immunobiology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK.; Zippelius A; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland. alfred.zippelius@usb.ch.; Medical Oncology, University Hospital Basel, Basel, Switzerland. alfred.zippelius@usb.ch.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Kirchhammer N; Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel 4031, Switzerland.; Trefny MP; Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel 4031, Switzerland.; Auf der Maur P; Tumor Heterogeneity, Metastasis and Resistance, Department of Biomedicine, University and University Hospital of Basel, Basel 4031, Switzerland.; Läubli H; Cancer Immunotherapy, Department of Biomedicine, University and University Hospital Basel, Basel 4031, Switzerland.; Medical Oncology, University Hospital Basel, Basel 4031, Switzerland.; Zippelius A; Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel 4031, Switzerland.; Medical Oncology, University Hospital Basel, Basel 4031, Switzerland.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Kirchhammer N; Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.; Trefny MP; Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.; Natoli M; Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.; Brücher D; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.; Smith SN; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.; Werner F; Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.; Koch V; Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.; Schreiner D; Immune Cell Biology, Department of Biomedicine, University Hospital Basel, 4031 Basel, Switzerland.; Bartoszek E; Microscopy Core Facility, Department of Biomedicine, University Hospital Basel, 4031 Basel, Switzerland.; Buchi M; Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.; Schmid M; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.; Breu D; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.; Hartmann KP; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.; Zaytseva P; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.; Thommen DS; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 Amsterdam, Netherlands.; Läubli H; Medical Oncology, University Hospital Basel, 4031 Basel, Switzerland.; Böttcher JP; Institute of Molecular Immunology and Experimental Oncology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.; Stanczak MA; Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.; Kashyap AS; Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.; Plückthun A; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.; Zippelius A; Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.; Medical Oncology, University Hospital Basel, 4031 Basel, Switzerland.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Bayerl F; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Meiser P; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Donakonda S; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany; German Center for Infection Research, Munich, Germany.; Hirschberger A; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Lacher SB; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Pedde AM; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Hermann CD; Institute of Experimental Oncology, School of Medicine, Technical University of Munich, Munich, Germany.; Elewaut A; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.; Knolle M; Institute for Artificial Intelligence in Medicine & Healthcare, School of Medicine, Technical University of Munich, Munich, Germany.; Ramsauer L; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Rudolph TJ; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Grassmann S; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich, Munich, Germany.; Öllinger R; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich, Germany.; Kirchhammer N; Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Trefny M; Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Anton M; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Wohlleber D; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Höchst B; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany.; Zaremba A; Department for Dermatology, University Hospital Essen, Essen, Germany.; Krüger A; Institute of Experimental Oncology, School of Medicine, Technical University of Munich, Munich, Germany.; Rad R; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich, Germany.; Obenauf AC; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.; Schadendorf D; Department for Dermatology, University Hospital Essen, Essen, Germany.; Zippelius A; Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Buchholz VR; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich, Munich, Germany.; Schraml BU; Walter-Brendel Center for Experimental Medicine, LMU Munich, Planegg-Martinsried, Germany; Biomedical Center, Institute for Cardiovascular Physiology and Pathophysiology, LMU Munich, Planegg-Martinsried, Germany.; Böttcher JP; Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany. Electronic address: j.boettcher@tum.de.
Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE
Academic Journal
Fernandez-Rodriguez L; Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Cianciaruso C; Department of Pathology and Immunology, University of Geneva, Geneve, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland.; Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts, USA.; Bill R; Department of Pathology and Immunology, University of Geneva, Geneve, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland.; Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts, USA.; Trefny MP; Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Klar R; Secarna Pharmaceuticals GmbH & Co KG, Planegg Martinsried, Germany.; Kirchhammer N; Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Buchi M; Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Festag J; Secarna Pharmaceuticals GmbH & Co KG, Planegg Martinsried, Germany.; Michel S; Secarna Pharmaceuticals GmbH & Co KG, Planegg Martinsried, Germany.; Kohler RH; Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts, USA.; Jones E; Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Maaske A; Secarna Pharmaceuticals GmbH & Co KG, Planegg Martinsried, Germany.; Vom Berg J; Institute of Laboratory Animal Science, University of Zurich, Zürich, Switzerland.; Kobold S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.; German Center for Lung Research (DZL), German Center for Translational Cancer Research (DKTK), partner site Munich, Munich, Germany.; Kashyap AS; Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Jaschinski F; Secarna Pharmaceuticals GmbH & Co KG, Planegg Martinsried, Germany.; Dixon KO; Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Pittet MJ; Department of Pathology and Immunology, University of Geneva, Geneve, Switzerland mikael.pittet@unige.ch alfred.zippelius@usb.ch.; AGORA Cancer Research Center, Lausanne, Switzerland.; Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts, USA.; Ludwig Institute for Cancer Research Lausanne Branch, Lausanne, Switzerland.; Zippelius A; Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland mikael.pittet@unige.ch alfred.zippelius@usb.ch.; Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Wang J; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Manni M; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Bärenwaldt A; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Wieboldt R; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Kirchhammer N; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Ivanek R; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.; Stanczak M; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Zippelius A; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Division of Oncology, Department of Theragnostic, University Hospital Basel, Basel, Switzerland.; König D; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Division of Oncology, Department of Theragnostic, University Hospital Basel, Basel, Switzerland.; Rodrigues Manutano N; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Läubli H; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Division of Oncology, Department of Theragnostic, University Hospital Basel, Basel, Switzerland.
Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
Academic Journal
Lötscher J; Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland.; Martí I Líndez AA; Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; Department of Medicine, CITIID, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK.; Kirchhammer N; Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland.; Cribioli E; Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland; Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland.; Giordano Attianese GMP; Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland; Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland.; Trefny MP; Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland.; Lenz M; University of Applied Science Northwestern Switzerland, Institute for Ecopreneurship, 4132 Muttenz, Switzerland.; Rothschild SI; Division of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, 4031 Basel, Switzerland; Swiss Group for Clinical Cancer Research, 3008 Bern, Switzerland.; Strati P; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Künzli M; Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland.; Lotter C; Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland.; Schenk SH; Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland.; Dehio P; Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland.; Löliger J; Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland.; Litzler L; Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland.; Schreiner D; Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland.; Koch V; Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland.; Page N; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Lee D; Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland.; Grählert J; Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland.; Kuzmin D; Hornet Therapeutics Ltd, London SW1Y 5ES, UK; Department of Medical Oncology, Yale School of Medicine, New Haven, CT 06510, USA.; Burgener AV; Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland.; Merkler D; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Pless M; Swiss Group for Clinical Cancer Research, 3008 Bern, Switzerland; Department of Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.; Balmer ML; Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland; Department for Biomedical Research (DBMR), University Clinic for Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, University of Bern, 3008 Bern, Switzerland; Diabetes Center Berne (DCB), 3010 Bern, Switzerland.; Reith W; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.; Huwyler J; Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland.; Irving M; Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland; Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland.; King CG; Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland.; Zippelius A; Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland; Division of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, 4031 Basel, Switzerland.; Hess C; Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland; Department of Medicine, CITIID, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK. Electronic address: chess@uhbs.ch.
Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Academic Journal
Rodrigues Mantuano N; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Stanczak MA; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Oliveira IA; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Kirchhammer N; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Filardy AA; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Monaco G; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Santos RC; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Fonseca AC; Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil.; Fontes M; Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil.; Bastos CS Jr; Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil.; Dias WB; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Zippelius A; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Oncology, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.; Todeschini AR; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. heinz.laeubli@unibas.ch adrianet@biof.ufrj.br.; Läubli H; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland. heinz.laeubli@unibas.ch adrianet@biof.ufrj.br.; Division of Oncology, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Academic Journal
Bonilla WV; University of Basel, Department of Biomedicine, Basel, Switzerland.; Kirchhammer N; University of Basel, Department of Biomedicine, Basel, Switzerland.; Marx AF; University of Basel, Department of Biomedicine, Basel, Switzerland.; Kallert SM; University of Basel, Department of Biomedicine, Basel, Switzerland.; Krzyzaniak MA; University of Basel, Department of Biomedicine, Basel, Switzerland.; Lu M; University of Basel, Department of Biomedicine, Basel, Switzerland.; Darbre S; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Schmidt S; Hookipa Pharma Inc., Vienna, Austria.; Raguz J; Hookipa Pharma Inc., Vienna, Austria.; Berka U; Hookipa Pharma Inc., Vienna, Austria.; Vincenti I; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Pauzuolis M; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Kerber R; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Hoepner S; Tumor Immunology, Department for BioMedical Research, University of Bern, Bern, Switzerland.; Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Magnus C; Institute of Virology, University of Zurich, Zurich, Switzerland.; Merkler D; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Division of Clinical Pathology, University Hospitals of Geneva, Geneva, Switzerland.; Orlinger KK; Hookipa Pharma Inc., Vienna, Austria.; Zippelius A; University of Basel, Department of Biomedicine, Basel, Switzerland.; Medical Oncology, University Hospital Basel, Basel, Switzerland.; Pinschewer DD; University of Basel, Department of Biomedicine, Basel, Switzerland.
Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med
Academic Journal
Wege AK; Clinic of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany. Anja.Wege@ukr.de.; Kirchhammer N; Clinic of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.; Department of Biomedicine, University of Basel, Basel, Switzerland.; Kazandjian LV; MAB Discovery GmbH, Polling, Germany.; Prassl S; MAB Discovery GmbH, Polling, Germany.; Brandt M; MAB Discovery GmbH, Polling, Germany.; Piendl G; Clinic of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.; Ortmann O; Clinic of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.; Fischer S; MAB Discovery GmbH, Polling, Germany.; Brockhoff G; Clinic of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Kirchhammer, N.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어